Plagiarism Policy

Pharmatera Journal is committed to maintaining academic integrity, scientific originality, and publication quality through the implementation of a strict plagiarism prevention policy. All manuscripts submitted for publication must be original scholarly works, must not have been previously published, and must be free from plagiarism and other forms of publication misconduct.

To ensure manuscript originality, the Editorial Board of Pharmatera Journal conducts similarity checks using plagiarism detection software, namely Turnitin. The journal establishes a maximum similarity index of 20%, while taking into consideration the nature of the similarities, the accuracy of citations, and the scientific content of the manuscript.

A similarity percentage does not automatically indicate plagiarism. Therefore, all similarity reports are carefully evaluated by the Editorial Board to determine whether any violations of academic integrity have occurred.

1. Definition of Plagiarism

Plagiarism is the act of intentionally or unintentionally copying, using, reproducing, or presenting another person's ideas, concepts, theories, data, methods, research findings, or scholarly works as one's own without providing appropriate acknowledgment or proper citation of the original sources.

Plagiarism constitutes a violation of academic honesty, scientific originality, and research integrity.

2. Types of Plagiarism

Pharmatera Journal recognizes several forms of plagiarism, including:

  1. Direct Plagiarism: Copying parts or the entirety of another author's work without appropriate quotation or acknowledgment of the original source.

  2. Paraphrasing Plagiarism: Rewriting or modifying another author's words, sentences, or ideas without providing proper attribution.

  3. Idea Plagiarism: Using another researcher's ideas, concepts, theories, methodologies, or research findings without appropriate acknowledgment.

  4. Self-Plagiarism: Reusing substantial portions of one's previously published work without adequate disclosure or appropriate citation.

  5. Data Plagiarism: Using data, tables, figures, graphs, or research findings belonging to other researchers without proper acknowledgment and permission when required.

  6. Complete Plagiarism: Submitting an entire scholarly work created by another person and presenting it as one's own original research.

3. Plagiarism Screening Procedure

All manuscripts submitted to Pharmatera Journal undergo an originality assessment before proceeding to the peer-review stage.

The plagiarism screening procedure includes the following steps:

  1. The Editorial Board conducts a similarity assessment using Turnitin plagiarism detection software.

  2. Manuscripts with a similarity index of 20% or below may proceed to further editorial evaluation, provided that no substantial plagiarism is identified.

  3. Manuscripts with a similarity index exceeding 20% will undergo further editorial assessment and may be returned to the authors for revision or rejected, depending on the evaluation results.

  4. The Editorial Board reserves the right to conduct additional examinations of citations, references, and the originality of the manuscript's scientific content.

  5. If plagiarism is suspected, the Editor-in-Chief will review the case and determine the appropriate editorial action based on the nature and severity of the violation.

4. Levels of Plagiarism and Editorial Actions

Pharmatera Journal applies proportionate editorial actions according to the severity of plagiarism identified in a submitted manuscript.

a. Minor Plagiarism

Minor plagiarism involves copying a limited number of sentences or short passages from other scholarly works without appropriate citation, provided that the originality of the manuscript's scientific contribution is not substantially compromised.

Editorial Action: Authors will receive a written notification and will be required to revise the manuscript, including correcting quotations, paraphrasing, and references in accordance with the journal's guidelines.

b. Moderate Plagiarism

Moderate plagiarism involves the unauthorized use of substantial portions of text, concepts, or scientific information from other sources without proper acknowledgment, affecting the originality of the manuscript.

Editorial Action: The manuscript may be returned to the authors for substantial revision or rejected at the discretion of the Editorial Board. Revised manuscripts must undergo an additional originality screening.

c. Severe Plagiarism

Severe plagiarism involves reproducing substantial portions or the entirety of another author's scholarly work, misappropriating research data or findings, or committing serious violations of academic integrity.

Editorial Action: The manuscript will be rejected for publication in Pharmatera Journal. The Editorial Board may impose restrictions on future submissions in accordance with the journal's policies and the findings of the investigation. Where appropriate, the case may be reported to the authors' affiliated institutions following the principles and procedures recommended by the Committee on Publication Ethics (COPE).

5. Authors' Responsibilities

All authors submitting manuscripts to Pharmatera Journal are responsible for ensuring the originality, accuracy, and scientific integrity of their work.

Authors are required to ensure that:

  1. The submitted manuscript represents original scholarly work and does not contain plagiarism.

  2. All quotations, theories, data, figures, tables, and sources of information are properly acknowledged and cited.

  3. The manuscript has not been previously published and is not currently under consideration by another journal.

  4. Each listed author has made a legitimate scholarly contribution to the manuscript.

  5. All authors have reviewed and approved the final manuscript and agreed to its submission to Pharmatera Journal.

  6. Authors are willing to cooperate with editorial investigations, clarification requests, and revisions if potential violations of publication ethics are identified.

Authors must submit a Publication Ethics Statement in accordance with the journal's submission requirements as a formal declaration of their commitment to originality and academic integrity.

6. Simultaneous Submission and Duplicate Publication

Pharmatera Journal does not accept manuscripts that are simultaneously submitted to or under review by other journals.

If an author is found to have submitted the same manuscript to multiple journals simultaneously or engaged in duplicate publication without appropriate disclosure, the Editorial Board reserves the right to reject the manuscript and notify relevant parties in accordance with established publication ethics procedures.

7. Handling Plagiarism After Publication

If suspected plagiarism is identified after an article has been published, Pharmatera Journal will conduct an objective investigation and provide the authors with an opportunity to respond to the allegations.

Depending on the findings, the Editorial Board may take the following actions:

  1. Correction: A correction notice may be issued when citation or attribution errors can be appropriately resolved without compromising the scientific validity of the published article.

  2. Expression of Concern: An expression of concern may be published when serious allegations of misconduct remain unresolved or when an investigation is ongoing and its findings are inconclusive.

  3. Retraction: An article may be retracted when substantial plagiarism or serious publication misconduct has been confirmed and the article should no longer be regarded as a reliable contribution to the scientific literature.

  4. Institutional Notification: Relevant institutions may be informed when further investigation or action concerning serious academic misconduct is necessary.

All corrections, expressions of concern, and retractions will be handled transparently, fairly, and in accordance with recognized publication ethics principles.

8. Final Provisions

By submitting a manuscript to Pharmatera Journal, all authors acknowledge that they have read, understood, and agreed to comply with the journal's plagiarism policy and publication ethics requirements.

Pharmatera Journal reserves the right to investigate suspected violations and take appropriate editorial actions before or after publication while upholding the principles of fairness, transparency, academic integrity, and responsible scholarly publishing.

This policy is guided by the publication ethics principles established by the Committee on Publication Ethics (COPE) and internationally recognized standards of responsible scholarly publishing.

References: